title: Biochemical and histopathological correlation in liver transplant: the first 180 days.
abstract: It is not known whether the histopathology of the liver allograft can be predicted from biochemical measurements in serum with the same confidence as in the native liver. To answer this question we compared the histopathological diagnoses in 170 biopsy specimens from 70 adult transplant recipients obtained during the first 180 days, with the concentrations of the serum bilirubin and the activities of AST, ALT and alkaline phosphatase measured at the same time. The most frequent diagnosis was cholestasis (n = 45), which was mild, moderate or severe and which may have been complicated by rejection (n = 28) or ischemia (n = 14). Hepatitis (n = 14), ischemia with rejection (n = 6) and spotty focal necrosis (n = 6) were diagnosed less frequently. Fifteen biopsy specimens were reported as histopathologically normal. In general, biochemical measurements discriminated poorly between different histopathological diagnoses. The histopathologically normal liver often showed an abnormal pattern of enzymes and an increase in the serum bilirubin level. As a result histopathologically normal biopsy specimens were indistinguishable biochemically from those with hepatitis. When two pathological conditions were found to coexist (e.g., cholestasis with either rejection or ischemic necrosis, or ischemic necrosis with rejection), the effect on the serum biochemistry was usually not additive and in some instances returned the biochemical abnormalities toward normal. With the exception of the serum bilirubin level, which increased with the severity of uncomplicated cholestasis, we could not identify a specific pattern of biochemical changes corresponding to a given histopathological diagnosis.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Internal Medicine, University of Michigan Medical School, Ann Arbor 48109.
authors.forename: K S
authors.initials: KS
authors.lastname: Henley
authors.forename: M R
authors.initials: MR
authors.lastname: Lucey
authors.forename: H D
authors.initials: HD
authors.lastname: Appelman
authors.forename: P
authors.initials: P
authors.lastname: Baliga
authors.forename: K A
authors.initials: KA
authors.lastname: Brown
authors.forename: G D
authors.initials: GD
authors.lastname: Burtch
authors.forename: D A
authors.initials: DA
authors.lastname: Campbell
authors.forename: J M
authors.initials: JM
authors.lastname: Ham
authors.forename: R M
authors.initials: RM
authors.lastname: Merion
authors.forename: J G
authors.initials: JG
authors.lastname: Turcotte
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood*; D001663:Bilirubin / Q000097:blood*; D001706:Biopsy; D002779:Cholestasis / Q000097:blood / Q000473:pathology*; D003937:Diagnosis, Differential; D006084:Graft Rejection; D006505:Hepatitis / Q000097:blood / Q000473:pathology*; D006801:Humans; D007511:Ischemia / Q000097:blood / Q000473:pathology*; D008099:Liver / Q000098:blood supply / Q000473:pathology*; D016031:Liver Transplantation / Q000473:pathology*; D009336:Necrosis; D013997:Time Factors
chemical_list: D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin